RespireRx Pharmaceuticals Inc. (RSPI)
USD 0.0
(-23.81%)
USD 0.0
(-23.81%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -143.9 Thousand | -956.17 Thousand | -513 Thousand | -487.74 Thousand | -427.36 Thousand | -697 Thousand |
| Net Income | -2.1 Million | -3.14 Million | -4.3 Million | -2.11 Million | -2.59 Million | -4.29 Million |
| Depreciation & Amortization | 390.91 Billion | 552.78 Billion | 374.08 Billion | 215.57 Billion | 8.37 Billion | 5167.00 |
| Deferred income taxes | - | -552.78 Billion | -374.08 Billion | -994.98 Billion | -8.37 Billion | - |
| Stock-based compensation | 2000.00 | 58.75 Thousand | 384.25 Thousand | 779.4 Billion | 29.24 Thousand | 4.5 Million |
| Change in working capital | 1.46 Million | 1.65 Million | 2.54 Million | 1.43 Million | 1.84 Million | -862.51 Thousand |
| Other non-cash items | -1078.21 Billion | 476.27 Thousand | 863.41 Thousand | 190.19 Thousand | 69.5 Thousand | -58.15 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | 5.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 142.59 Thousand | 956.74 Thousand | 497.13 Thousand | 471.15 Thousand | 375.75 Thousand | 689.87 Thousand |
| Debt repayment | -24.81 Thousand | -828.86 Thousand | -334.25 Thousand | -500.9 Thousand | -180 Thousand | -64.62 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 117.29 Thousand | 162.88 Thousand | - | 195.75 Thousand | 754.5 Thousand |
| Other Financing Activities | 142.59 Thousand | 1.66 Million | 668.5 Thousand | 972.05 Thousand | 375.75 Thousand | 689.87 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 482.28 Thousand | 605.82 Thousand | 1.26 Million | 524.32 Thousand | 703.68 Thousand | 476.44 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 986.19 Thousand | 1.04 Million | 1.27 Million | 912.77 Thousand | 1.14 Million | -1.33 Million |
| Cash at beginning of period | 1398.00 | 825.00 | 16.69 Thousand | 33.28 Thousand | 84.9 Thousand | 92.04 Thousand |
| Cash at end of period | 88.00 | 1398.00 | 825.00 | 16.69 Thousand | 33.28 Thousand | 84.9 Thousand |
| Capital Expenditure | 5.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1310.00 | 573.00 | -15.86 Thousand | -16.59 Thousand | -51.61 Thousand | -7138.00 |
| Free Cash Flow | -143.9 Thousand | -956.17 Thousand | -513 Thousand | -487.74 Thousand | -427.36 Thousand | -697 Thousand |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -395.5 Thousand | -681.03 Thousand | -430.06 Thousand | -2.1 Million | -289.69 Thousand | -472.57 Thousand |
| Depreciation & Amortization | - | - | 6540.00 | 390.91 Billion | 390.91 Billion | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 185.3 Thousand | 2000.00 | -2000.00 | 2000.00 |
| Change in working capital | 177.91 Thousand | 557.97 Thousand | 421.91 Thousand | 1.46 Million | 115.7 Thousand | 366.02 Thousand |
| Other non-cash items | 116.62 Thousand | -5527.00 | -212.88 Thousand | -1078.21 Billion | -390.91 Billion | 34.61 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 100 Thousand | 135.76 Thousand | 29.23 Thousand | 142.59 Thousand | -11.12 Thousand | 69.97 Thousand |
| Debt repayment | - | -95 Thousand | -29.23 Thousand | -24.81 Thousand | -19.49 Thousand | -57.06 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 100 Thousand | 70 Thousand | - | - | -1500.00 | - |
| Other Financing Activities | 100.00 | 160.76 Thousand | 29.23 Thousand | 142.59 Thousand | -11.12 Thousand | 69.97 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 595.19 Thousand | 33.34 Thousand | 172.62 Thousand | 482.28 Thousand | 43.33 Thousand | 134.56 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -417.28 Thousand | 524.63 Thousand | 249.29 Thousand | 986.19 Thousand | 72.37 Thousand | 231.45 Thousand |
| Cash at beginning of period | 7321.00 | 138.00 | 88.00 | 1398.00 | 60.00 | 21.00 |
| Cash at end of period | 6362.00 | 7321.00 | 138.00 | 88.00 | 88.00 | 60.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -959.00 | 7183.00 | 50.00 | -1310.00 | 28.00 | 39.00 |
| Free Cash Flow | -100.95 Thousand | -128.57 Thousand | -29.18 Thousand | -143.9 Thousand | 11.15 Thousand | -69.93 Thousand |
300452
ISLAX
SEAC
CAPTW
GNYPF
MBHCF